Skip to main content
EVGN
NASDAQ Industrial Applications And Services

Evogene braces for proxy fight with massive share authorization and reverse split on the table

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.471
Mkt Cap
$4.904M
52W Low
$0.37
52W High
$1.5
52W Position info
27% above low
Off High info
69% below high
Rel. Volume
Market data snapshot near publication time

EVGN sits 27% above its 52-week low of $0.37.

Summary

Evogene's proxy filing reveals a high-stakes board battle with activist shareholders, alongside proposals for a massive share authorization increase and a reverse split. The September 4 meeting will decide control of the company.


Key Events · Corporate Governance and Compliance · EVGN

  • Contested Board Election

    Shareholders will choose between the Evogene Slate of 7 directors and the Pure Capital Slate of 4 directors, nominated by activists holding 17.41%. The winning slate takes full control.

  • Massive Authorized Share Increase Proposed

    Proposal 2 seeks to boost authorized shares from 30M to 150M — a 400% increase — to provide flexibility for Nasdaq compliance, strategic transactions, and general corporate purposes.

  • Reverse Split Framework Sought

    Proposal 3 asks for authority to implement a reverse split between 1-for-2 and 1-for-15 within 18 months, primarily to regain Nasdaq's $1 minimum bid price compliance by the September 28 deadline.

  • Executive Departure

    VP Business Development Olga Nissan stepped down effective July 31, 2026. A replacement search is underway.


Analysis · EVGN · Industrial Applications And Services

A contested election looms as Evogene's board faces an activist group that already holds 17.41% and has been accumulating more shares. At the same time, shareholders are being asked to approve a 400% increase in authorized shares and a reverse split framework — tools that could serve either to fend off the activists or to raise dilutive capital. The September 4 vote will determine who controls the company and its strategic direction, while the departure of the VP of Business Development adds further uncertainty.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EVGN was trading at $0.47 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.9M. The 52-week trading range was $0.37 to $1.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Nov 16, 2026, 7:01 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3646
Real-time Price: $0.3531 info
Change: -$0.0115 (-3%) info
Market Cap: $7.071M info
EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.3531 info
Change: -$0.057 (-14%) info
Market Cap: $7.071M info
EVGN
Sep 30, 2026, 7:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4168
Real-time Price: $0.3531 info
Change: -$0.0637 (-15%) info
Market Cap: $7.071M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.3531 info
Change: -$0.0376 (-10%) info
Market Cap: $7.071M info
EVGN
Sep 15, 2026, 5:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.5281
Real-time Price: $0.3531 info
Change: -$0.175 (-33%) info
Market Cap: $7.071M info